CBD Life Sciences Inc. (CBDL)

CBD Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 12, 2026	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2	0	0	8	5	0
Market Cap Growth	47.02%	4.42%	-99.50%	62.45%	909.61%	154.02%
Enterprise Value	1	-0	-0	8	5	1
Last Close Price	0.00	0.00	0.00	0.06	0.48	0.43
PS Ratio	9.58	0.25	0.25	97.63	22.19	6.23
PB Ratio	4.99	1.00	0.30	6.11	-406.26	0.48
P/TBV Ratio	11.10	-	-	6.98	-	-
EV/Sales Ratio	8.09	-	-	98.38	22.46	8.37
Debt / Equity Ratio	-	-	-	-	-	0.41
Net Debt / Equity Ratio	0	-0.06	0.00	-0.77	0.32	0.39
Net Debt / EBITDA Ratio	0.00	0.11	0.00	-	-	-1.18
Net Debt / FCF Ratio	0.00	0.15	0.00	0.16	0.01	-0.52
Asset Turnover	-	0.61	0.19	-	-	0.10
Inventory Turnover	-	6.04	2.75	-	-	-
Quick Ratio	3.95	0.01	0.00	-	-	0.87
Current Ratio	4.16	0.12	0.05	-	-	4.66
Return on Equity (ROE)	-45.08%	-88.73%	-117.18%	-930.04%	-332.59%	-163.08%
Return on Assets (ROA)	-	-17.95%	-64.47%	-	-	-30.66%
Return on Capital Employed (ROCE)	-31.40%	-184.40%	-639.30%	-450.40%	-	-28.30%
Earnings Yield	-6.29%	-184.85%	-2112.23%	-75.43%	-33.81%	-173.46%
FCF Yield	-	-39.15%	-2145.09%	-79.16%	-13.18%	-154.93%
Buyback Yield / Dilution	-8.24%	-	-73.92%	-2403.73%	-125.06%	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 12, 2026

Data Sources Report a data error